Cargando…

Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies

Anti-glial nuclear antibody (AGNA) is an onconeuroal antibody targeting the nuclei of Bergmann glia in the cerebellum and Anti-SRY-related HMG-box 1 (SOX1). It is highly specific for small cell lung cancer (SCLC) and correlates to the appearance of paraneoplastic neurological syndromes such as Lambe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feldheim, Jonas, Deuschl, Cornelius, Glas, Martin, Kleinschnitz, Christoph, Hagenacker, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142469/ https://www.ncbi.nlm.nih.gov/pubmed/34030742 http://dx.doi.org/10.1186/s42466-021-00129-w

Ejemplares similares

Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome with SOX-1 Antibodies
por: Wada, Shinichi, et al.
Publicado: (2020)

Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx
por: Takasugi, Junji, et al.
Publicado: (2017)

Paraneoplastic Cerebellar Degeneration With P/Q-VGCC vs Yo Autoantibodies
por: Winklehner, Michael, et al.
Publicado: (2022)

Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report
por: AGOSTINI, Andrea, et al.
Publicado: (2021)

Educational Case: Lambert–Eaton syndrome
por: Huddleston, Austin, et al.
Publicado: (2022)

Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022)

Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma
por: Dohrn, Maike F., et al.
Publicado: (2020)

Lambert-Eaton Myasthenic Syndrome in Lung Cancer
por: Wang, Yongbin, et al.
Publicado: (2022)

Anti‐SOX1 antibody‐positive paraneoplastic neurological syndrome presenting with Lambert‐Eaton myasthenic syndrome and small cell lung cancer: A case report
por: Li, Chunyang, et al.
Publicado: (2019)

Lambert-Eaton Myasthenic Syndrome; Pathogenesis, Diagnosis, and Therapy
por: Gilhus, Nils Erik
Publicado: (2011)

Lambert-Eaton Myasthenic syndrome: early diagnosis is key
por: Ivanovski, Trajche, et al.
Publicado: (2019)

Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
por: Bukhari, Sumera, et al.
Publicado: (2017)

Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
por: Yoshikawa, Hiroaki, et al.
Publicado: (2022)

Pseudomyopathic Changes in Needle Electromyography in Lambert-Eaton Myasthenic Syndrome
por: Komatsu, Teppei, et al.
Publicado: (2013)

Recent Advances and Therapeutic Options in Lambert-Eaton Myasthenic Syndrome
por: Anwar, Arsalan, et al.
Publicado: (2019)

A Patient with Coexisting Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome
por: Kim, Jee-Ae, et al.
Publicado: (2012)

Pure Ocular Weakness as the Initial Manifestation of Lambert–Eaton Myasthenic Syndrome
por: Katyal, Nakul, et al.
Publicado: (2017)

Stimulated single-fiber electromyography (sSFEMG) in Lambert-Eaton syndrome
por: Todisco, Vincenzo, et al.
Publicado: (2018)

Pulmonary Large Cell Neuroendocrine Carcinoma Associated With Lambert-Eaton Syndrome
por: Hernandez-Arriaga, Pamela, et al.
Publicado: (2021)

Update on treatment options for Lambert–Eaton myasthenic syndrome: focus on use of amifampridine
por: Lindquist, Sabine, et al.
Publicado: (2011)

The association between Lambert–Eaton myasthenic syndrome and small cell lung carcinoma
por: Briggs, Sarah EW, et al.
Publicado: (2013)

3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia
por: Sanders, Donald B., et al.
Publicado: (2018)

Lung cancer prediction in Lambert-Eaton myasthenic syndrome in a prospective cohort
por: Maddison, Paul, et al.
Publicado: (2020)

Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
por: Pascuzzi, Robert M, et al.
Publicado: (2022)

Unusual paraneoplastic syndromes in pancreatic cancer: a case report of Lambert-Eaton myasthenic syndrome (LEMS) associated with intraductal papillary mucinous cancer of the pancreas
por: Zamparas, Athanasios, et al.
Publicado: (2023)

A Case of Lambert-Eaton Myasthenic Syndrome Associated with Atypical Bronchopulmonary Carcinoid Tumor
por: Lee, Jae-Hyeok, et al.
Publicado: (2004)

Neuroendocrine carcinoma of the seminal vesicles presenting with Lambert Eaton syndrome: a case report
por: Kreiner, Benedikt, et al.
Publicado: (2010)

Lambert‐Eaton myasthenic syndrome with anti‐acetylcholine receptor antibody and anterior mediastinal tumor
por: Matsumoto, Hideyuki, et al.
Publicado: (2017)

Lowering the cutoff value for increment increases the sensitivity for the diagnosis of Lambert‐Eaton myasthenic syndrome
por: Lipka, Alexander F., et al.
Publicado: (2020)

Neuromuscular Active Zone Structure and Function in Healthy and Lambert-Eaton Myasthenic Syndrome States
por: Ginebaugh, Scott P., et al.
Publicado: (2022)

Durvalumab for Extensive-Stage of Small-Cell Lung Cancer With Lambert-Eaton Myasthenic Syndrome
por: Machiyama, Hirotomo, et al.
Publicado: (2023)

Treatment of Paraneoplastic Cerebellar Degeneration
por: Greenlee, John E.
Publicado: (2013)

Update on Paraneoplastic Cerebellar Degeneration
por: Loehrer, Philipp Alexander, et al.
Publicado: (2021)

Five years experience on 3,4-diaminopyridine phosphate in Lambert–Eaton syndrome: Case reports
por: Portaro, Simona, et al.
Publicado: (2017)

Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer
por: Nakatani, Yuki, et al.
Publicado: (2018)

Population Pharmacokinetics/Pharmacodynamics of 3,4‐Diaminopyridine Free Base in Patients With Lambert‐Eaton Myasthenia
por: Thakkar, Nilay, et al.
Publicado: (2017)

Long‐term follow‐up, quality of life, and survival of patients with Lambert‐Eaton myasthenic syndrome
por: Lipka, Alexander F., et al.
Publicado: (2020)

The European Lambert–Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment
por: Meisel, Andreas, et al.
Publicado: (2022)

Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer
por: Kunii, Eiji, et al.
Publicado: (2021)

Atezolizumab-Induced Lambert-Eaton Myasthenic Syndrome in a Patient With Small-Cell Lung Cancer
por: Yamazoe, Masami, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_65qajn2fum9kfi9gm494q17tsu